new_0222_0379|GLUE|0|total_current_assets|cash_on_hand|inventories_net|net_ppe|goodwill_and_intangible|liabilities|total_current_liabilities|total_long_term_liab|total_deposits|book_value_of_equity|retained_earnings|treasury_stock|ev_revenues|ev_earnings|ev_free_cash_flow|ev_assets|ps_ratio|pe_ratio|price_to_book_value|peg_ratio|debt_equity_ratio|dividend_yield|shareholder_yield_ttm|percent_of_shares_outstanding|receivables|payables|capital_stock|return_on_invested_capital|quality_ratio_fractile|momentum_fractile|market_beta_12_month|sustainable_growth_rate|institutional_investor_ownership_percentage|average_shares_outs_diluted|total_employee_number|eps|shares_outstanding|repurchase_of_capital_stock|ordinary_shares_number|payout_ratio|quick_ratio|normalized_eps|stock_buyback|effective_tax_rate|return_on_equity|net_income_ttm|revenues_ttm|dividend_per_share|revenues|gross_profit|sga_expense|pre_tax_income|net_income|interest_income|price|total_return_price|enterprise_value|average_volume_30|one_year_return|price_next_month|price_second_month
new_0222_0379|GLUE|1|Monte Rosa Therapeutics Inc Total Current Assets (Quarterly) (USD)|Monte Rosa Therapeutics Inc Cash and Short Term Investments (Quarterly) (USD)|Monte Rosa Therapeutics Inc Inventories (Quarterly) (USD)|Monte Rosa Therapeutics Inc Net PP&E (Quarterly) (USD)|Monte Rosa Therapeutics Inc Goodwill and Intangibles (Quarterly) (USD)|Monte Rosa Therapeutics Inc Total Liabilities (Quarterly) (USD)|Monte Rosa Therapeutics Inc Total Current Liabilities (Quarterly) (USD)|Monte Rosa Therapeutics Inc Total Long Term Liabilities (Quarterly) (USD)|Monte Rosa Therapeutics Inc Total Deposits (Quarterly) (USD)|Monte Rosa Therapeutics Inc Book Value (Quarterly) (USD)|Monte Rosa Therapeutics Inc Retained Earnings (Quarterly) (USD)|Monte Rosa Therapeutics Inc Treasury Stock (Quarterly) (USD)|Monte Rosa Therapeutics Inc EV to Revenues|Monte Rosa Therapeutics Inc EV to Earnings|Monte Rosa Therapeutics Inc EV to Free Cash Flow|Monte Rosa Therapeutics Inc EV to Assets (Quarterly)|Monte Rosa Therapeutics Inc PS Ratio|Monte Rosa Therapeutics Inc PE Ratio|Monte Rosa Therapeutics Inc Price to Book Value|Monte Rosa Therapeutics Inc PEG Ratio|Monte Rosa Therapeutics Inc Debt to Equity Ratio|Monte Rosa Therapeutics Inc Dividend Yield|Monte Rosa Therapeutics Inc Shareholder Yield (TTM)|Monte Rosa Therapeutics Inc Percent of Shares Outstanding Short|Monte Rosa Therapeutics Inc Total Receivables (Quarterly) (USD)|Monte Rosa Therapeutics Inc Total Payables (Quarterly) (USD)|Monte Rosa Therapeutics Inc Total Capital Stock (Quarterly) (USD)|Monte Rosa Therapeutics Inc Return on Invested Capital|Monte Rosa Therapeutics Inc Quality Ratio Score|Monte Rosa Therapeutics Inc Momentum Score|Monte Rosa Therapeutics Inc Beta (1Y)|Monte Rosa Therapeutics Inc Sustainable Growth Rate (TTM)|Monte Rosa Therapeutics Inc Institutional Investor Ownership Percentage|Monte Rosa Therapeutics Inc Average Diluted Shares Outstanding (Quarterly)|Monte Rosa Therapeutics Inc Total Employees (Annual)|Monte Rosa Therapeutics Inc EPS Diluted (Quarterly) (USD)|Monte Rosa Therapeutics Inc Shares Outstanding|Monte Rosa Therapeutics Inc Repurchase of Capital Stock (Quarterly) (USD)|Monte Rosa Therapeutics Inc Ordinary Shares Number (Quarterly)|Monte Rosa Therapeutics Inc Payout Ratio|Monte Rosa Therapeutics Inc Quick Ratio (Quarterly)|Monte Rosa Therapeutics Inc Normalized Diluted EPS (Quarterly) (USD)|Monte Rosa Therapeutics Inc Stock Buybacks (Quarterly) (USD)|Monte Rosa Therapeutics Inc Effective Tax Rate (TTM)|Monte Rosa Therapeutics Inc Return on Equity|Monte Rosa Therapeutics Inc Net Income (TTM) (USD)|Monte Rosa Therapeutics Inc Revenue (TTM) (USD)|Monte Rosa Therapeutics Inc Dividend Per Share (Quarterly) (USD)|Monte Rosa Therapeutics Inc Revenue (Quarterly) (USD)|Monte Rosa Therapeutics Inc Gross Profit (Quarterly) (USD)|Monte Rosa Therapeutics Inc SG&A Expense (Quarterly) (USD)|Monte Rosa Therapeutics Inc Pre-Tax Income (Quarterly) (USD)|Monte Rosa Therapeutics Inc Net Income (Quarterly) (USD)|Monte Rosa Therapeutics Inc Net Interest Income (Quarterly) (USD)|Monte Rosa Therapeutics Inc Price (USD)|Monte Rosa Therapeutics Inc Total Return Price (USD)|Monte Rosa Therapeutics Inc Enterprise Value (USD)|Monte Rosa Therapeutics Inc 30-Day Average Daily Volume|Monte Rosa Therapeutics Inc 1 Year Price Returns (Daily)||
new_0222_0379|GLUE|2|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|percent_USD_metric|percent_USD_metric|percent_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|percent_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_beta|percent_USD_metric|percent_USD_metric|mil_figure_USD_metric|figure_whole_USD_metric|figure_money_USD_per_share_metric|mil_figure_USD_metric|mil_figure_money_USD_metric|mil_figure_USD_metric|percent_USD_metric|figure_USD_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|percent_USD_metric|percent_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_money_USD_price|figure_money_USD_price|mil_figure_money_USD_metric|figure_USD_metric|percent_USD_metric||
new_0222_0379|GLUE|4|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|daily|quarterly|quarterly|quarterly|daily|quarterly|quarterly|daily|quarterly|monthly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|monthly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|daily|daily|daily|daily|quarterly||
new_0222_0379|GLUE|5|91|91|0|91|0|91|91|91|0|91|91|0|0|0|1.44242424242|0|0|0|1.43827160494|0|0|1.44242424242|0|15.3571428571|0|91|91|0|0|0|0|0|0|91.3333333333|50.5|91.3333333333|23.5|0|91|0|0|91.3333333333|91.4|0|0|91|0|0|0|0|91.3333333333|91.3333333333|91.3333333333|91.3333333333|1.43975903614|1.43975903614|1.44242424242|1.44117647059|0||
new_0222_0379|GLUE|6|3|3|0|3|0|3|3|3|0|3|3|0|0|0|165|0|0|0|162|0|0|165|0|14|0|3|3|0|0|0|0|0|0|6|2|6|6|0|3|0|0|6|5|0|0|3|0|0|0|0|6|6|6|6|166|166|165|136|0||
new_0222_0379|GLUE|7|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|daily|quarterly|daily|quarterly|daily|daily|daily|daily|quarterly|daily|quarterly|daily|quarterly|quarterly|quarterly|quarterly|quarterly|monthly|monthly|quarterly|monthly|quarterly|yearly|quarterly|daily|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|market_daily|market_daily|daily|market_daily|market_daily||
new_0222_0379|GLUE|202003||||||||||||||||||||||||||||||||||21.7378||-0.1979||||||-0.1976|||||||||0.478|-4.302|-4.302|-0.003|||||||
new_0222_0379|GLUE|202006||||||||||||||||||||||||||||||||||21.7378||-0.2468||||||-0.2482|0||||||||0.541|-5.364|-5.364|0.001|||||||
new_0222_0379|GLUE|202009||||||||||||||||||||||||||||||||||21.7378||-0.3017||||||-0.2937|0||||||||0.914|-6.558|-6.558|0.002|||||||
new_0222_0379|GLUE|202012|43.591|41.699||4.623||98.106|29.275|68.831||-48.728|-48.077|||||||||||||||7.066|0.001|||||||21.7378||-0.9042|||42.5402|||-0.902||||-35.88|||||2.073|-19.656|-19.656|0.009|||||||
new_0222_0379|GLUE|202103|171.707|168.436||7.732||241.219|9.091|232.128||-60.616|-60.353|||||||||||||||7.326|0.001|||||||21.7378||-0.2886|||42.5402|||-0.5684||||-43.854|||||2.231|-12.276|-12.276|0.006|||||||
new_0222_0379|GLUE|202106|358.289|357.06||8.923||12.263|10.791|1.472||356.678|-78.758||||-13.1362||||2.8387|||0||1.6531||7.463|0.004|||||||5.0706|83|-3.63|44.6037||44.6037|||-3.5716|-206.739|||-56.895|||||3.486|-18.405|-18.405|0.014|21.18|21.18|773.8664|201138.1||23.49|38.72
new_0222_0379|GLUE|202109|370.519|367.034||11.801||14.744|12.743|2.001||369.305|-98.595||||-10.8501||||3.1053|||0||5.4342||3.53|0.005|||||||45.9879|94|-0.43|46.4839||46.4839|||-0.4304|-31.011|||-70.174|||||4.753|-19.837|-19.837|0.013|23.88|23.88|750.5398|277197.6667||23.45|20.55
new_0222_0379|GLUE|202112||346.071||||18.814|||||||||-9.4544||||2.5488|||0||7.1817||||||||||||-0.5037|46.536|||||||||-73.958|||||5.257||-23.44||20.24|20.24|574.2454|158977.7667||11.34|13.8
new_0222_0379|GLUE|202203||317.163||||20.13|||||||||||||1.7014|||||||||||||||||-0.51|46.6307|||||||||-85.614|||||6.387||-23.932||12.68|12.68|245.2012|403895.2667||12.11|7.74
new_0222_0379|GLUE|202206||294.145||||63.006|||||||||||||1.3705|||||||||||||||||-0.57|46.6847|||||||||-93.678|||||6.295||-26.469||9.57|9.57|129.4536|265684.6667||10.63|7.91
new_0222_0379|GLUE|202209||272.149||||66.511|||||||||||||1.2001|||||||||||||||||-0.58|48.3728|||||||||-101.159|||||7.02||-27.318||7.76|7.76|68.3549|248969.3667||7.88|8.44
new_0222_0379|GLUE|202212||262.826||||70.976|||||||||||||1.129|||||||||||||||||-0.63|49.3235|||||||||-108.501|||||7.621||-30.782||6.79|6.79|56.4809|136715.1||7.4|6.08
new_0222_0379|GLUE|202303||231.734||||65.302|||||||||||||1.2312|||||||||||||||||-0.65|49.361|||||||||-116.607|||||7.504||-32.038||6.77|6.77|71.3344|107843.6667||4.64|6.52
new_0222_0379|GLUE|202306||203.066||||64.962|||||||||||||1.3798|||||||||||||||||-0.71|49.5925|||||||||-125.316|||||8.145||-35.178||6.81|6.81|104.569|189148.6667||6.87|6.28
new_0222_0379|GLUE|202309||178.477||||67.579|||||||||||||1.3062|||||||||||||||||-0.7|50.0657|||||||||-132.882|||||8.661||-34.884||5.62|5.62|76.0193|174082.9||2.5|2.97
new_0222_0379|GLUE|202312||232.413||||124.505|||||||||||||1.5334|||||||||||||||||-0.58|50.1402||||||0.116|||-135.352|||||7.728||-33.252||5.65|5.65|109.9896|267958.9667||5.43|5.72
new_0222_0379|GLUE|202403||192.892||||114.227|||||||||||||2.1573|||||||||||||||||-0.53|50.2003|||||||||-135.282|||1.064||8.985||-31.968||7.71|7.71|120.6719|147890.8||5.61|4.18
new_0222_0379|GLUE|202406||262.205||||119.443|||||||||||||1.5196|||||||||||||||||-0.43|61.3283||||||-47.945|||-130.414|||4.695||9.282||-30.31||3.79|3.79|13.7967|275317.4||4.48|6.77
new_0222_0379|GLUE|202409||242.186||||109.623|||||||||||||1.5543|||||||||||||||||-0.29|61.3775||||||0.641|||-119.389|||9.216||8.127||-23.859||5.69|5.69|55.0924|345354.3667||9.37|8.6
new_0222_0379|GLUE|202412||372.149||||215.796|||||||||||6.7802||1.9147|||||||||||||||||0.2185|61.5074||||||47.001|||-72.7|75.622||60.647||8.777||13.437||6.94|6.94|191.5571|1518757.1667||5.82|5.78
new_0222_0379|GLUE|202503||326.074||||118.039|||||||||||2.3153|67.7758|1.5644|||||||||||||||||0.57|61.5098|||||||||6.153|159.487||84.929||8.703||46.885||5.67|5.67|-58.449|666515.9333||4.79|3.99
new_0222_0379|GLUE|202506|||||||||||||||||2.2504|65.8769|1.0596||||||||||||||||||||||||||||||||||||4.74|4.74|-32.6723|455610.5667||4.87|